"Mouth Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the MOUTH.
Descriptor ID |
D009062
|
MeSH Number(s) |
C04.588.443.591 C07.465.565
|
Concept/Terms |
Mouth Neoplasms- Mouth Neoplasms
- Mouth Neoplasm
- Neoplasm, Mouth
- Neoplasms, Oral
- Neoplasm, Oral
- Oral Neoplasm
- Oral Neoplasms
- Neoplasms, Mouth
Cancer of Mouth- Cancer of Mouth
- Mouth Cancers
- Mouth Cancer
- Cancer, Mouth
- Cancers, Mouth
- Oral Cancer
- Cancer, Oral
- Cancers, Oral
- Oral Cancers
- Cancer of the Mouth
|
Below are MeSH descriptors whose meaning is more general than "Mouth Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Mouth Neoplasms".
This graph shows the total number of publications written about "Mouth Neoplasms" by people in this website by year, and whether "Mouth Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
2000 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 3 | 0 | 3 |
2004 | 1 | 1 | 2 |
2005 | 2 | 1 | 3 |
2006 | 1 | 0 | 1 |
2007 | 3 | 1 | 4 |
2008 | 2 | 0 | 2 |
2009 | 2 | 1 | 3 |
2010 | 6 | 0 | 6 |
2011 | 4 | 1 | 5 |
2012 | 3 | 0 | 3 |
2013 | 7 | 1 | 8 |
2014 | 5 | 0 | 5 |
2015 | 6 | 2 | 8 |
2016 | 6 | 0 | 6 |
2017 | 3 | 3 | 6 |
2018 | 5 | 0 | 5 |
2019 | 6 | 2 | 8 |
2020 | 6 | 0 | 6 |
2021 | 4 | 0 | 4 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mouth Neoplasms" by people in Profiles.
-
Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol. 2022 11; 134:106127.
-
Association of Changes in Medicaid Dental Benefits With Localized Diagnosis of Oral Cavity Cancer. JAMA Oncol. 2022 05 01; 8(5):778-780.
-
Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100411.
-
Neoadjuvant presurgical PD-1 inhibition in oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100426.
-
The Substantial Omission of Indicated Postoperative Radiotherapy in Patients With Advanced-Stage Oral Cancer in the US-A Call to Action. JAMA Otolaryngol Head Neck Surg. 2021 10 01; 147(10):907-909.
-
Association between periodontal disease and oral cancer screening among US adults: NHANES 2011-2014. Community Dent Oral Epidemiol. 2022 06; 50(3):216-224.
-
Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma. Cancer. 2020 10 15; 126(20):4498-4510.
-
Grading systems of oral cavity pre-malignancy: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2020 Nov; 277(11):2967-2976.
-
Plexiform Schwannoma of the Oral Cavity: Report of Eight Cases and a Review of the Literature. Head Neck Pathol. 2021 Mar; 15(1):288-297.
-
Toxic epidermal necrolysis accompanied by several immune-related adverse events developed after discontinuation of nivolumab. Eur J Cancer. 2020 05; 131:1-4.